Fact CheckerSign in

NCT06905132RecruitingPhase 2

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma: A Single Institution Phase II Trial

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

The purpose of this research study is to preserve healthy tissue around the cancer on the arm(s) and/or leg(s) using Hypofractionated radiotherapy, while treating the cancer and preventing it from spreading to other areas of the body.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
First submitted
12 Mar 2025
Start date
1 Apr 2025
Primary completion date
27 Mar 2029
Lead sponsor
Medical University of South Carolina
Diseases
Sarcoma
NCT number
NCT06905132

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 40
  • From 1 Apr 2025 to the primary completion date, 27 Mar 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior radiation therapy in the proposed treatment area
  • Women who are pregnant or plan to become pregnant during the period of radiation therapy
  • Planned concurrent administration of chemotherapy and radiation therapy

Other illness

  • Distant metastatic disease
  • Simultaneous treatment of another malignancy

Who the study is looking for

  • Willingness and provision of informed consent via signed and dated copy.
  • Histologically confirmed STS of extremity or trunk.
  • Male or female, aged greater than or equal to 18 years old
  • ECOG performance status 0-3
  • Meets screening criteria for receipt of radiotherapy.
  • Deemed eligible for wide local excision.
  • Patient and/or physician identified possible barriers to receiving a 5-week course of conventionally fractionated preoperative radiotherapy. Potential barriers include but are not limited to concern for local progression that could precluded or complicate limb sparing surgery, concern for distant progression that could result in patient being non-operative, financial and/or physical burden of travel for daily treatments, financial burden of time away from work or caregiving.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medical University of South Carolina
Coordinator of this site? Confirm its status
CharlestonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.